< 生产厂家价格 >

2,2':6',2''-三吡啶

2,2':6',2''-三吡啶用途

光度法测定银、铁和钌的试剂。

点击显示

2,2':6',2''-三吡啶名称

[ CAS 号 ]:
1148-79-4

[ 中文名 ]:
α,α,α-三联吡啶

[ 英文名 ]:
2,2':6',2''-TERPYRIDINE

[中文别名 ]:

[英文别名 ]:

2,2′﹕6′,2′′-Terpyridine
2,2′:6′,2′′-Terpyridine
EINECS 214-559-5
tcmdc-123985
terpy
2,2',2''-Terpyridine
α,α',α''-Tripyridyl
2,6-Di(2-pyridyl)pyridine
2,2':6',2''-Terpyridine
Terpyridine

2,2':6',2''-三吡啶物理化学性质

[ 密度 ]:
1.2±0.1 g/cm3

[ 沸点 ]:
402.3±35.0 °C at 760 mmHg

[ 熔点 ]:
90-93 °C

[ 分子式 ]:
C₁₅H₁₁N₃

[ 分子量 ]:
233.268

[ 闪点 ]:
182.5±18.9 °C

[ 精确质量 ]:
233.095291

[ PSA ]:
38.67000

[ LogP ]:
2.13

[ 外观性状 ]:
黄色到黄色-绿色到棕色粉末或晶体

[ 蒸汽压 ]:
0.0±0.9 mmHg at 25°C

[ 折射率 ]:
1.615

[ 储存条件 ]:
室温

[ 水溶解性 ]:
dioxane: 0.1 g/mL, clear

2,2':6',2''-三吡啶MSDS

2,2':6',2''-三吡啶安全信息

[ 符号 ]:

GHS05, GHS06

[ 信号词 ]:
Danger

[ 危害声明 ]:
H300-H310-H315-H318-H335

[ 警示性声明 ]:
P261-P264-P280-P302 + P350-P305 + P351 + P338-P310

[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ 危害码 (欧洲) ]:
T+: Very toxic;

[ 风险声明 (欧洲) ]:
R27/28

[ 安全声明 (欧洲) ]:
S26-S28-S36/37/39-S45

[ 危险品运输编码 ]:
UN 2811 6.1/PG 1

[ WGK德国 ]:
3

[ 包装等级 ]:
I

[ 危险类别 ]:
6.1

[ 海关编码 ]:
2933399090

2,2':6',2''-三吡啶合成路线

2,2':6',2''-三吡啶上下游产品

2,2':6',2''-三吡啶上游产品

2,2':6',2''-三吡啶下游产品

2,2':6',2''-三吡啶海关

[ 海关编码 ]: 2933399090

[ 中文概述 ]:
2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

2,2':6',2''-三吡啶文献

Thousands of chemical starting points for antimalarial lead identification.

Nature 465 , 305-10, (2010)

Malaria is a devastating infection caused by protozoa of the genus Plasmodium. Drug resistance is widespread, no new chemical class of antimalarials has been introduced into clinical practice since 19...

Metal complexes with superoxide dismutase-like activity as candidates for anti-prion drug.

Bioorg. Med. Chem. Lett. 16 , 5982-7, (2006)

Various compounds were evaluated for ability to inhibit the formation of the abnormal protease-resistant form of prion protein (PrP-res) in two cell lines infected with different prion strains. Examin...

In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.

Proc. Natl. Acad. Sci. U. S. A. 105 , 9059-64, (2008)

The growing resistance to current first-line antimalarial drugs represents a major health challenge. To facilitate the discovery of new antimalarials, we have implemented an efficient and robust high-...

更多文献